Bitter Pills:Medicines & The Third World Poor | Page 238

in 1982 contain no warnings about oral rehydration. But Dr. Nicolsonof G. D. Searle writes:
"We have agreed that the importance of replenishng fluid and salts in the treatment of diarrhoea
particularly in children is something which should be further emphasised in our literature
(advertising, package inserts, etc.) It is true that the problem of dehydration in the context
of diarrhoea may not be fully appreciated by physicians in private or public health practice.
While we may help in the educational process by providing responsible information, the problem
is one which must be tackled fundamentally in professional medical education on a worldwide
basis." (Personal communication, 25 March 1982.)
30

ABPI, Data Sheet Compendium,

31

"Lomotil for Diarrhoea in Children", The Medical Letter, (25, 1975) p. 104, quoted by Charles
Medawar and Barbara Freese, Drug Diplomacy, Social Audit Ltd, 1982, pp. 12-13.

1979-80, p.936.

32

S. M. Uthman, "Some complications of Diphenozylate Hydrochloride with Atropine",
Lebanese Medical Journal, 27.5,1974, pp.521-2, quoted by Medawar and Freese, 1982, op.cit.,
pp.12-13.

33

G. Upunda, J. Yudkin andG. Brown, Therapeutic Guidelines, (A Manual to assist in the rational
purchase and prescription of drugs), African Medical and Research Foundation (AMREF),
Nairobi, 1980, p.96, quoted in ibid.

34

"Lomotil for Diarrhoea in Children", in The Medical Letter, 25,1975, p. 104, quoted in ibid.

35

M. E. Drake and M. E. Drake Jr., "Lomotil Intoxication in Pediatric Patients", J. Med.
Soc. New Jersey, June 1974, pp.501-2, quoted in ibid.

36

Ibid., p.8.

37

ABPI, Data Sheet Compendium 1979-80, p.936.

38

Medawar and Freese, op.cit., p. 16.

39

-

40

SCRIP, No 630, 30 September, 1981, p.11.

41

AMREF, 1980, quoted by Medawar and Freese, op. cit., pp. 12-13 Worldwide Sales of Lomotil
in 1981 totalled $31.2 million (SCRIP 684, 14 April 1982).

42

Medawar and Freese, op.cit.

43

"You have raised the question of communicating information to the illiterate. This problem
we presume, is not one which confronts only Searle or the pharmaceutical industry. Your
practical suggestions will be welcomed and considered." (Dr. Nicholson, Searle Research and
Development (UK), personal communication, 25 March 1982.)

British National Formulary 1981, No. 1, op. cit., p.40.
WHO, 1976, op. cit.

44

Dr. Olle Hansson, "Is Entero-Vioform a killer drug?", New Scientist, 23 November 1978.

45

-

46

ICADIS News, No 1, Information Centre Against Drug-Induced Sufferings, Japan, November
1981.

47

-

Hansson, op. cit.
Prof. Rawlins of Committee of Safety of Medicines, in interview with the author, 31
March 1982.

48

-

British National Formulary 1981. Unigreg's Unidiarea (125 mg clioqunol and 200 mg
neomycin sulphate).
UK MIMS, February 1980.

Parish, op. cit., p.137.
Hansson, op. cit.

49

WHO, Drug Information Bulletin, WHO, Geneva, January-March 1978.

50

-

Dr. D. M. Burley, Head of International Medical Liaison, Ciba-Geigy, Horsham, England,
personal communication 4 February 1982.

231